1058 related articles for article (PubMed ID: 7912457)
41. Analysis of CD4 and CD2 receptor function.
Goldman SJ; Bierer BE; Burakoff SJ
Princess Takamatsu Symp; 1988; 19():149-60. PubMed ID: 2908352
[TBL] [Abstract][Full Text] [Related]
42. Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway.
Karmann K; Hughes CC; Fanslow WC; Pober JS
Eur J Immunol; 1996 Mar; 26(3):610-7. PubMed ID: 8605928
[TBL] [Abstract][Full Text] [Related]
43. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.
Hünig T; Tiefenthaler G; Meyer zum Büschenfelde KH; Meuer SC
Nature; 1987 Mar 19-25; 326(6110):298-301. PubMed ID: 3102975
[TBL] [Abstract][Full Text] [Related]
44. A 19-kDa human erythrocyte molecule H19 is involved in rosettes, present on nucleated cells, and required for T cell activation. Comparison of the roles of H19 and LFA-3 molecules in T cell activation.
Groux H; Huet S; Aubrit F; Tran HC; Boumsell L; Bernard A
J Immunol; 1989 May; 142(9):3013-20. PubMed ID: 2468708
[TBL] [Abstract][Full Text] [Related]
45. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions.
Nakamura T; Takahashi K; Fukazawa T; Koyanagi M; Yokoyama A; Kato H; Yagita H; Okumura K
J Immunol; 1990 Dec; 145(11):3628-34. PubMed ID: 1700989
[TBL] [Abstract][Full Text] [Related]
46. Human T cell activation: participation of Tll antigen (CD2, T,gp.50) in T cell-accessory cell interactions.
Suthanthiran M
Transplant Proc; 1987 Feb; 19(1 Pt 1):336-7. PubMed ID: 2908550
[No Abstract] [Full Text] [Related]
47. Functional CD2 mutants unable to bind to, or be stimulated by, LFA-3.
Wolff HL; Burakoff SJ; Bierer BE
J Immunol; 1990 Feb; 144(4):1215-20. PubMed ID: 1689346
[TBL] [Abstract][Full Text] [Related]
48. Role of CD2 in activation and cytotoxic function of CD8/Leu-7-positive T cells.
Rüthlein J; James SP; Strober W
J Immunol; 1988 Dec; 141(11):3791-7. PubMed ID: 2903195
[TBL] [Abstract][Full Text] [Related]
49. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor.
Bockenstedt LK; Goldsmith MA; Dustin M; Olive D; Springer TA; Weiss A
J Immunol; 1988 Sep; 141(6):1904-11. PubMed ID: 2459194
[TBL] [Abstract][Full Text] [Related]
50. T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2.
Bierer BE; Hahn WC
Semin Immunol; 1993 Aug; 5(4):249-61. PubMed ID: 7693022
[TBL] [Abstract][Full Text] [Related]
51. Unusual expression of CD2 in sheep: implications for T cell interactions.
Mackay CR; Hein WR; Brown MH; Matzinger P
Eur J Immunol; 1988 Nov; 18(11):1681-8. PubMed ID: 2462499
[TBL] [Abstract][Full Text] [Related]
52. The "erythrocyte receptor" of T-lymphocytes and T11 target structure (T11TS): complementary cell interaction molecules involved in T-cell activation.
Hünig T; Tiefenthaler G; Mitnacht R; Köhler C; Lottspeich F; Meuer S
Behring Inst Mitt; 1987 Jun; (81):31-40. PubMed ID: 2888455
[TBL] [Abstract][Full Text] [Related]
53. Activation of human dendritic cells by porcine aortic endothelial cells: transactivation of naïve T cells through costimulation and cytokine generation.
Manna PP; Duffy B; Olack B; Lowell J; Mohanakumar T
Transplantation; 2001 Nov; 72(9):1563-71. PubMed ID: 11707746
[TBL] [Abstract][Full Text] [Related]
54. A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction.
Takahashi K; Nakamura T; Koyanagi M; Kato K; Hashimoto Y; Yagita H; Okumura K
J Immunol; 1990 Dec; 145(12):4371-9. PubMed ID: 1979586
[TBL] [Abstract][Full Text] [Related]
55. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
[TBL] [Abstract][Full Text] [Related]
56. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
Capey S; van den Berg CW
Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
[TBL] [Abstract][Full Text] [Related]
57. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro.
Böhmig GA; Kovarik J; Holter W; Pohanka E; Zlabinger GJ
J Immunol; 1994 Apr; 152(8):3720-8. PubMed ID: 7511657
[TBL] [Abstract][Full Text] [Related]
58. Involvement of LFA-1/ICAM and CD2/LFA-3 in human endothelial cell accessory function.
Westphal JR; Willems HW; Ruiter DJ; De Waal RM
Behring Inst Mitt; 1993 Aug; (92):51-62. PubMed ID: 7504456
[TBL] [Abstract][Full Text] [Related]
59. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
[TBL] [Abstract][Full Text] [Related]
60. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function.
Moingeon P; Chang HC; Wallner BP; Stebbins C; Frey AZ; Reinherz EL
Nature; 1989 May; 339(6222):312-4. PubMed ID: 2566919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
